Curtana Pharmaceuticals, a biotechnology company focused on improving outcomes for brain cancer patients, is proud to announce the publication of two pioneering studies in Nature Communications.
15,000 smiles and counting: OneSolution® Dental Implant Centers marks an important milestone in the number of life-changing full-mouth implant procedures performed for patients, setting the standard of care expected in South Florida.
Immunology Consultants Laboratory, a leading provider of innovative antibodies and immunoassays, is excited to announce the appointment of Dr. Eric McIntush as its new Chief Executive Officer (CEO), effective January 13, 2025. Dr.
Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical, has been named Chair of the Industrial Advisory Board for the Penn State Center for Biodevices. A founding member of the board since its inception in August 2020, Dr.
OneSolution® Dental Implant Centers now offers a Lifetime Warranty on its OneSolution® Zirconia Hybrid teeth, giving patients confidence in their dental restorations.
$RENB is working with large $NVDA partner Nebul developing AI and Biotechnology Platforms for Early Diagnosis, Better-Targeted Treatments and Drug Discovery
Dr. James Fetsch, general dentist and full-arch specialist, recently became a keynote speaker for the Full Arch Growth Conference in Orlando, FL, an event focused on growing full-arch dental implant practices worldwide. Dr.
Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study.
Today, the Arizona Pharmacy Association (AzPA), the leading voice for Arizona's pharmacy professionals, announced the appointment of Garet Turner as its new Chief Executive Officer.
1016 views, By OneSolution® Dental Implant Centers
OneSolution® Dental Implant Centers is now providing innovative zygomatic dental implant solutions, offering hope to patients who have been told they don't qualify for traditional implants due to severe bone loss.
In the fast-moving biotechnology world, where speed and precision are key, Creative Biolabs is making waves with its high throughput antibody production services.
Sano Women's Health has received investigational new drug approval from the FDA, for Occidiofungin, a first-in-class novel peptide with broad antifungal activity.
Curtana Pharmaceuticals, a biotechnology company focused on improving outcomes for brain cancer patients, is proud to announce the publication of two pioneering studies in Nature Communications.
The global CT scanner market was valued at USD 6.94 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2032, reaching an estimated value of USD 11.75 billion by the end of the forecast period.
Manhattan BioSolutions, Inc. ("MABS"), an emerging biotechnology company developing new classes of precision biologics that harness natural host defense mechanisms, today announced that its RNA-targeting therapeutic, MABS-139, will be evaluated in...
Disrupting the healthcare consulting landscape, Improzo Inc. is rapidly gaining traction with its innovative approach that tackles modern challenges and prioritizes patients.
Oak Therapeutics, a pioneering early-stage life sciences company, announces the successful development of an innovative Oral Dissolvable Strip (ODS) formulation for the treatment of HIV/AIDS in infants and young children.
The global diabetes insulin delivery pen market size was valued at USD 17.7 Billion in 2023 and is likely to reach USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period.
15,000 smiles and counting: OneSolution® Dental Implant Centers marks an important milestone in the number of life-changing full-mouth implant procedures performed for patients, setting the standard of care expected in South Florida.
Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$2.8 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 10.5%
Clinion has been recognised with the prestigious SCDM Innovation Award for Clinical Data Science Implementation Excellence at the 2024 SCDM Annual Conference in Boston.
The United States proton therapy market size was valued at USD 1 billion in 2024 and is projected to hit around USD 2.5 billion by 2033, growing at a CAGR of 12% during the forecast period 2025 to 2033.
Immunology Consultants Laboratory, a leading provider of innovative antibodies and immunoassays, is excited to announce the appointment of Dr. Eric McIntush as its new Chief Executive Officer (CEO), effective January 13, 2025. Dr.
Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical, has been named Chair of the Industrial Advisory Board for the Penn State Center for Biodevices. A founding member of the board since its inception in August 2020, Dr.
OneSolution® Dental Implant Centers now offers a Lifetime Warranty on its OneSolution® Zirconia Hybrid teeth, giving patients confidence in their dental restorations.
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development.
